Patent information
IP India · live recordApplication number
202317046747
Filing date
12 July 2023
Status
Application Awaiting Examination
Publication number
48/2023
Publication type
INA
Invention field
Chemical
Abstract
Compounds of formula (1) wherein R1 represents a -C(R2)(R3)-[C(R4)(R5)]m-L-R6 group or -R7; and the preparation and the therapeutic uses of the compounds of formula (1) as agonists of TRPM8 receptors, useful especially in the treatment of oropharyngeal dysphagia.
Applicants
1France
SANOFI
46 avenue de la Grande Armée
75017 Paris
Inventors
9U.S.A.
MUELLER, Paul, Justinc/o Sanofi
55 Corporate Drive
Mail Code 55A-525
Bridgewater, NJ 08807
France
AUGER, Florianc/o Sanofi
54 rue La Boétie
75008 Paris
France
BEGIS, Guillaumec/o Sanofi
54 rue La Boétie
75008 Paris
France
FORICHER, Yannc/o Sanofi
54 rue La Boétie
75008 Paris
Germany
GREBNER, Christophc/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main
France
HOURCADE, Stephanec/o Sanofi
54 rue La Boétie
75008 Paris
France
MEYFROOT, Stephaniec/o Sanofi
54 rue La Boétie
75008 Paris
Germany
RUF, Svenc/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main
Germany
WIRTH, Klausc/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main
Documents
Sign in to openApplication documents
1
202317046747-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [12-07-2023(online)].pdf
12 Jul 2023
2
202317046747-STATEMENT OF UNDERTAKING (FORM 3) [12-07-2023(online)].pdf
12 Jul 2023
3
202317046747-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [12-07-2023(online)].pdf
12 Jul 2023
4
202317046747-FORM 1 [12-07-2023(online)].pdf
12 Jul 2023
5
202317046747-DECLARATION OF INVENTORSHIP (FORM 5) [12-07-2023(online)].pdf
12 Jul 2023
6
202317046747-COMPLETE SPECIFICATION [12-07-2023(online)].pdf
12 Jul 2023
7
202317046747-FORM-26 [28-09-2023(online)].pdf
28 Sep 2023
8
202317046747-FORM 3 [12-01-2024(online)].pdf
12 Jan 2024
9
202317046747-FORM 18 [18-10-2024(online)].pdf
18 Oct 2024
10
202317046747-Proof of Right [31-12-2024(online)].pdf
31 Dec 2024